[Anticonvulsants and vitamin D metabolism (author's transl)].
D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001361:Avitaminosis / Q000139:chemically induced; D001835:Body Weight; D002118:Calcium / Q000378:metabolism; D002132:Calcium Radioisotopes; D002762:Cholecalciferol / Q000494:pharmacology / Q000627:therapeutic use; D004790:Enzyme Induction / Q000187:drug effects; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced; D007408:Intestinal Absorption; D008099:Liver / Q000201:enzymology; D008134:Long-Term Care; D051379:Mice; D010018:Osteomalacia / Q000139:chemically induced*; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D051381:Rats; D014807:Vitamin D / Q000378:metabolism*
D000927:Anticonvulsants; D002132:Calcium Radioisotopes; D014807:Vitamin D; D002762:Cholecalciferol; D010672:Phenytoin; D002118:Calcium; D010634:Phenobarbital
Antikonvulsiva und Vitamin-D-Stoffwechsel